A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface ...

Panelists reflect on clinical experience with immunotherapy combinations, the role of biomarkers, and the future of ...

The Cancer Society New Zealand is proud to announce over $1 million in funding for five ground-breaking research projects aimed at improving cancer prevention, detection and treatment for all New ...

Researchers at Wake Forest University developed a wearable patch that could help with early skin cancer detection.

Stage IIC melanoma patients in Sweden face worse survival than stage IIIA. Learn how this may change follow-up and treatment guidelines.

ACU's Eva Zopf has been awarded a significant World Cancer Research Fund grant to deliver important new insights into the ...

An announcement from Perspective Therapeutics ( ($CATX) ) is now available. On December 1, 2025, Perspective Therapeutics updated its corporate ...

Lifileucel showed a 31.4% objective response rate and a median duration of response of 36.5 months in advanced melanoma patients. The median overall survival was 13.9 months, with adverse events ...

Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.

About 10% of adolescents and young adults treated for solid tumors have a metastatic recurrence, with 5-year rates surpassing ...

"If it is a melanoma and it's undiagnosed, it's going to continue to progress," said Dr. Abby Waldman, the medical director of the Mohs and Dermatologic Surgery Center at Brigham and Women's Hospital.